Vice President, Clinical Development

Lyell Immunopharma(11 days ago)

Washington, Seattle, WA, United StatesOnsiteFull TimeSenior$300,000 - $360,000Clinical Development

About this role

A leading biotechnology company is developing next-generation CAR T-cell therapies for cancer treatment, focusing on improving outcomes for patients with solid tumors and hematologic malignancies. The company is committed to innovative science, collaboration, and producing transformative therapies that resist exhaustion and have durable effects.

View Original Listing

Required Skills

Clinical Development
Regulatory Strategy
Trial Design
Data Analysis
Team Leadership
Oncology
GCP
Regulatory Affairs
Therapy Development
Data Interpretation

About Lyell Immunopharma

lyell.com

Lyell is a fully integrated biopharmaceutical company developing next‑generation T‑cell reprogramming technologies to create durable CAR T‑cell therapies for hematologic malignancies and solid tumors. Their platform-driven approach spans discovery through clinical development, with active programs and trials such as the PiNACLE study for aggressive B‑cell non‑Hodgkin lymphoma and the recently acquired GCC‑targeted candidate LYL273. Lyell is patient‑focused, aiming to improve outcomes for cancers with significant unmet medical need.

View more jobs at Lyell Immunopharma →